Published in J Biomed Sci on May 24, 2010
Transmembrane helix dimerization: beyond the search for sequence motifs. Biochim Biophys Acta (2011) 1.26
A Single Amino Acid Substitution in the M Protein Attenuates Japanese Encephalitis Virus in Mammalian Hosts. J Virol (2015) 0.77
Sequence-dependent backbone dynamics of a viral fusogen transmembrane helix. Protein Sci (2012) 0.77
Glutamic acid at residue 125 of the prM helix domain interacts with positively charged amino acids in E protein domain II for Japanese encephalitis virus-like-particle production. J Virol (2014) 0.76
The I22V and L72S substitutions in West Nile virus prM protein promote enhanced prM/E heterodimerisation and nucleocapsid incorporation. Virol J (2015) 0.75
A structural perspective of the flavivirus life cycle. Nat Rev Microbiol (2005) 5.02
Visualization of membrane protein domains by cryo-electron microscopy of dengue virus. Nat Struct Biol (2003) 4.11
Statistical analysis of amino acid patterns in transmembrane helices: the GxxxG motif occurs frequently and in association with beta-branched residues at neighboring positions. J Mol Biol (2000) 3.95
Proteolytic activation of tick-borne encephalitis virus by furin. J Virol (1997) 3.78
Molecular organization of a recombinant subviral particle from tick-borne encephalitis virus. Mol Cell (2001) 3.23
Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form. J Virol (1995) 2.97
Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E. J Virol (1999) 2.87
Amino acid distributions in integral membrane protein structures. Biochim Biophys Acta (2001) 2.43
Insect cells as hosts for the expression of recombinant glycoproteins. Glycoconj J (1999) 2.40
The transmembrane domains of hepatitis C virus envelope glycoproteins E1 and E2 play a major role in heterodimerization. J Biol Chem (2000) 1.94
Enhancing biosynthesis and secretion of premembrane and envelope proteins by the chimeric plasmid of dengue virus type 2 and Japanese encephalitis virus. Virology (2003) 1.50
Dengue type 2 virus subviral extracellular particles produced by a stably transfected mammalian cell line and their evaluation for a subunit vaccine. Vaccine (2002) 1.36
Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles. J Virol (2001) 1.33
A functional epitope determinant on domain III of the Japanese encephalitis virus envelope protein interacted with neutralizing-antibody combining sites. J Virol (2003) 1.31
Transmembrane domains of hepatitis C virus envelope glycoproteins: residues involved in E1E2 heterodimerization and involvement of these domains in virus entry. J Virol (2006) 1.25
Japanese encephalitis virus antigenic variants with characteristic differences in neutralization resistance and mouse virulence. Virus Res (1997) 1.16
Ala-insertion scanning mutagenesis of the glycophorin A transmembrane helix: a rapid way to map helix-helix interactions in integral membrane proteins. Protein Sci (1996) 1.15
Secretion of noninfectious dengue virus-like particles and identification of amino acids in the stem region involved in intracellular retention of envelope protein. Virology (2005) 1.10
Histidine 39 in the dengue virus type 2 M protein has an important role in virus assembly. J Gen Virol (2004) 1.01
Interactions between the transmembrane segments of the alphavirus E1 and E2 proteins play a role in virus budding and fusion. J Virol (2003) 0.98
Noninfectious recombinant antigen for detection of St. Louis encephalitis virus-specific antibodies in serum by enzyme-linked immunosorbent assay. J Clin Microbiol (2004) 0.98
Role of the transmembrane domains of prM and E proteins in the formation of yellow fever virus envelope. J Virol (2003) 0.97
Formation of bovine viral diarrhea virus E1-E2 heterodimers is essential for virus entry and depends on charged residues in the transmembrane domains. J Gen Virol (2008) 0.96
Murray Valley encephalitis virus recombinant subviral particles protect mice from lethal challenge with virulent wild-type virus. Arch Virol (2002) 0.94
Single point mutation in tick-borne encephalitis virus prM protein induces a reduction of virus particle secretion. J Gen Virol (2004) 0.92
Alanine insertion scanning mutagenesis of lactose permease transmembrane helices. J Biol Chem (1997) 0.92
The conserved glycine residues in the transmembrane domain of the Semliki Forest virus fusion protein are not required for assembly and fusion. Virology (2005) 0.88
Complete nucleotide sequence and cell-line multiplication pattern of the attenuated variant CH2195LA of Japanese encephalitis virus. Virus Res (2001) 0.81
Structural basis of a flavivirus recognized by its neutralizing antibody: solution structure of the domain III of the Japanese encephalitis virus envelope protein. J Biol Chem (2003) 2.09
Is avian influenza A (H7N9) virus staggering its way to humans? J Formos Med Assoc (2013) 1.52
Review of dengue virus and the development of a vaccine. Biotechnol Adv (2010) 1.35
A functional epitope determinant on domain III of the Japanese encephalitis virus envelope protein interacted with neutralizing-antibody combining sites. J Virol (2003) 1.31
High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture. Vaccine (2006) 1.24
Recombinant trimeric HA protein immunogenicity of H5N1 avian influenza viruses and their combined use with inactivated or adenovirus vaccines. PLoS One (2011) 1.10
Production of EV71 vaccine candidates. Hum Vaccin Immunother (2012) 1.05
Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines. Vaccine (2008) 0.99
Dendritic cell activation by recombinant hemagglutinin proteins of H1N1 and H5N1 influenza A viruses. J Virol (2010) 0.94
Immunological evaluation and comparison of different EV71 vaccine candidates. Clin Dev Immunol (2012) 0.91
Production of inactivated influenza H5N1 vaccines from MDCK cells in serum-free medium. PLoS One (2011) 0.86
Detection of swine-origin influenza A (H1N1) viruses using a localized surface plasmon coupled fluorescence fiber-optic biosensor. Biosens Bioelectron (2010) 0.85
Broader neutralizing antibodies against H5N1 viruses using prime-boost immunization of hyperglycosylated hemagglutinin DNA and virus-like particles. PLoS One (2012) 0.84
Fabrication of influenza virus-like particles using M2 fusion proteins for imaging single viruses and designing vaccines. Vaccine (2011) 0.81
Different immunity elicited by recombinant H5N1 hemagglutinin proteins containing pauci-mannose, high-mannose, or complex type N-glycans. PLoS One (2013) 0.81
Dengue type 4 live-attenuated vaccine viruses passaged in vero cells affect genetic stability and dengue-induced hemorrhaging in mice. PLoS One (2011) 0.81
High genetic stability of dengue virus propagated in MRC-5 cells as compared to the virus propagated in vero cells. PLoS One (2008) 0.80
Heterologous prime-boost immunization regimens using adenovirus vector and virus-like particles induce broadly neutralizing antibodies against H5N1 avian influenza viruses. Biotechnol J (2013) 0.79
Mosquito and mammalian cells grown on microcarriers for four-serotype dengue virus production: variations in virus titer, plaque morphology, and replication rate. Biotechnol Bioeng (2004) 0.79
Formulation and immunological evaluation of a trivalent vaccine comprising emulsified submicron particles and inactivated virions of H5N1/EV71/JEV. Hum Vaccin Immunother (2013) 0.78
Influence of intron and exon splicing enhancers on mammalian cell expression of a truncated spike protein of SARS-CoV and its implication for subunit vaccine development. Vaccine (2005) 0.78
Identification of a heparin binding peptide from the Japanese encephalitis virus envelope protein. Biopolymers (2010) 0.77
A novel RNA silencing vector to improve antigen expression and stability in Chinese hamster ovary cells. Vaccine (2007) 0.77
Generating stable Chinese hamster ovary cell clones to produce a truncated SARS-CoV spike protein for vaccine development. Biotechnol Prog (2010) 0.76
Identification of mimotopes of the Japanese encephalitis virus envelope protein using phage-displayed combinatorial peptide library. J Mol Microbiol Biotechnol (2004) 0.75
Construction and characterization of insect cell-derived influenza VLP: cell binding, fusion, and EGFP incorporation. J Biomed Biotechnol (2010) 0.75
A novel E1B-55kD-deleted oncolytic adenovirus carrying mutant KRAS-regulated hdm2 transgene exerts specific antitumor efficacy on colorectal cancer cells. Mol Cancer Ther (2010) 0.75
Enhanced antibody affinity to Japanese encephalitis virus E protein by phage display. Biochem Biophys Res Commun (2007) 0.75
An intron promotes the anti-bcr-abl activities of a retrovirally expressed ribozyme in chronic myeloid leukemia cells. Biochem Biophys Res Commun (2004) 0.75
Using recombinant DNA technology for the development of live-attenuated dengue vaccines. Enzyme Microb Technol (2012) 0.75
Zika Virus Molecular Biology and Perspectives for Vaccine Development: A Review. J Nurs Res (2017) 0.75